A Phase 2 Study of the Effects of Sapropterin Dihydrochloride on Symptomatic Peripheral Arterial Disease
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether sapropterin dihydrochloride is safe and
effective in the treatment of intermittent claudication (IC) caused by peripheral arterial
disease (PAD).